US Patent 7446179 CD19-specific chimeric T cell receptor
Patent 7446179 was granted and assigned to City of Hope on November, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7446179 CD19-specific chimeric T cell receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
